相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine
Laura Papagno et al.
AIDS (2011)
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
Jonathan B. Angel et al.
AIDS (2011)
HIV-Specific CD4+ T Cells May Contribute to Viral Persistence in HIV Controllers
Peter W. Hunt et al.
CLINICAL INFECTIOUS DISEASES (2011)
Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
Jonathan Z. Li et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
Felipe Garcia et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
No Evidence for Decay of the Latent Reservoir in HIV-1-Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy
Rajesh T. Gandhi et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Didier Trono et al.
SCIENCE (2010)
Influence of a Vaccination Schedule on Viral Load Rebound and Immune Responses in Successfully Treated HIV-Infected Patients
Pedro Castro et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy
Carlum Shiu et al.
JOURNAL OF VIROLOGY (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)
Brigitte Autran et al.
AIDS (2008)
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
Thomas C. Greenough et al.
VACCINE (2008)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Candidate HIV-1 Tat vaccine development:: from basic science to clinical trials
Barbara Ensoli et al.
AIDS (2006)
Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals
Y Lévy et al.
AIDS (2006)
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
MC Strain et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Therapeutic Vaccines for chronic infections
B Autran et al.
SCIENCE (2004)
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
W Lu et al.
NATURE MEDICINE (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load
A Oxenius et al.
AIDS (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
MM Addo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
HF Günthard et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
